Coronavirus: mPharma plans to address drug supply shortage and price increase in Ghana

mPharma, a Ghanaian based pharmaceutical services company, says as Ghana battle the spread of COVID-19, it is looking to address what may be a potential drug supply shortage and price increases due to ongoing disruptions in the drug supply chains globally caused by the outbreak of Coronavirus.

Locally, mPharma is already aiming to address drug supply shortage and price increase for chronic patients in Ghana.

In a press statement, mPharma said "as we battle the spread of COVID-19, we are looking to address a potential drug supply shortage and price increases due to ongoing disruptions in the drug supply chains globally caused by the outbreak of Coronavirus. The organization is today launching a price control program for chronic patients dubbed "Mutti Keep My Price"

It said India has imposed export restrictions on 26 essential drugs according to ‘The Guardian’.

In Ghana, there are growing concerns about the possible shortage of medicines and the high price increase in some essential medical supplies such as the high cost of Hand Sanitizers.

Speaking to the media, a spokesperson for the organization said, “The Mutti Keep My Price program for patients on chronic medications will help patients choose between a 3 month or 6-month price control plan. The price of their covered medication will not change irrespective of what happens in the market during the duration of the plan”.

Mutti Keep My Price is free to enroll in.